49 results on '"Dayao, Zoneddy"'
Search Results
2. “Care needs to be integrated” Patient and provider perspectives on a cancer shared-care model
3. A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2
4. Developing a survivorship care plan (SCP) delivery process for patients and primary care providers serving poor, rural, and minority patients with cancer
5. Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A
6. Southwest Harvest for Health: Adapting a mentored vegetable gardening intervention for cancer survivors in the southwest
7. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
8. Improving Outpatient Infusion Clinic Wait Times at a Comprehensive Cancer Center
9. Developing Questions to Assess and Measure Patients’ Perceived Survival Benefit from Adjuvant Endocrine Therapy in Breast Cancer: A Mixed Methods Pilot Study
10. Abstract B069: Patient perspectives on reimagining survivorship care: A “Chipotle” model to enhance personalized cancer recovery
11. Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families
12. Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families
13. Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update
14. Improving the cancer survivorship journey: Developing a survivorship care transition model for rural and underserved low risk breast and gynecologic cancer patients (511)
15. Improving Sexual and Gender Minority Cancer Care: Patient and Caregiver Perspectives From a Multi-Methods Pilot Study
16. Abstract P4-10-01: Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)
17. Characterizing Low-Risk Breast and Gynecological Cancer Patients for Transition into an Oncology/Primary Care Coordinated Care Model: Findings from a Survey of Diverse Survivors in a Rural U.S. State
18. Southwest Harvest for Health: An Adapted Mentored Vegetable Gardening Intervention for Cancer Survivors
19. The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer
20. Patient, provider, and nurse preferences regarding patient-reported outcomes (PRO) and side effect management during cancer treatment of minority, rural and economically disadvantaged patients.
21. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
22. Pharmacist-Driven Oral Oncolytic Medication Education and Consent
23. Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105
24. Abstract B015: Women in survivorship health using Project ECHO: Creating a model for navigated care transitions
25. A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome.
26. Optimizing infusion wait time: Redesigning medication order verification/approval at a comprehensive cancer center.
27. Oral oncolytic education and adherence monitoring in poor, rural and minority patients.
28. Streamlining survivorship care plan (SCP) creation and delivery to primary care providers in poor, rural, and minority patients.
29. Abstract P6-11-10: Patient reported measures of a breast cancer nurse navigator program in a minority, rural, and economically disadvantaged patient population
30. Building a survivorship care plan delivery process: Experience in an academic center.
31. Pharmacist-driven oral oncolytic medication education and consent.
32. Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105.
33. Improving start-up times in oncology clinical trials: An ASCO quality improvement project.
34. The Conundrum of Adjuvant HER2 Treatment Options
35. HER2-targeted therapy for early-stage breast cancer: a comprehensive review
36. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature
37. Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families
38. Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families.
39. Association of CYP19A1 gene variants with differences in disease progression in breast cancer patients from different racial/ethnic backgrounds.
40. Abstract 1710: Quantitative 3D mapping of total choline in human breast cancer using high-speed MR spectroscopic imaging at 3T
41. The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer
42. Distant Metastases: A Surrogate Endpoint for Overall Survival in Early Breast Cancer?
43. Life-Threatening Bleeding from Refractory Acquired FVIII Inhibitor Successfully Treated with Rituximab
44. Aquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone
45. Patient-Reported Measures of a Breast Cancer Nurse Navigator Program in an Underserved, Rural, and Economically Disadvantaged Patient Population.
46. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update.
47. Life-Threatening Bleeding from Refractory Acquired FVIII Inhibitor Successfully Treated with Rituximab.
48. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
49. Developing Questions to Assess and Measure Patients' Perceived Survival Benefit from Adjuvant Endocrine Therapy in Breast Cancer: A Mixed Methods Pilot Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.